Evidence map›Paper›PMID 27457956›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.

Nilushi S De Silva, Michael M Anderson, Amanda Carette, Kathryn Silva, Nicole Heise, Govind Bhagat, Ulf Klein

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Regulation of BCR-mediated CaScience immunology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Nilushi S De SilvaHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032; Department of Microbiology and Immunology, Columbia University, New York, NY 10032;
Michael M AndersonHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;
Amanda CaretteHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;
Kathryn SilvaHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;
Nicole HeiseHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;
Govind BhagatHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032.
Ulf KleinHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032; Department of Microbiology and Immunology, Columbia University, New York, NY 10032; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032 uk30@cumc.columbia.edu.
Columbia University · USColumbia University Irving Medical Center · USHerbert Irving Comprehensive Cancer CenterSylvester Comprehensive Cancer Center · US

Funding

CELL, MOLECULAR AND DEVELOPMENTAL BIOLOGY OF CANCERT32CA009503 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GAUTIER, JEAN · 1985 to 2016
$6.8M
The Role of NF-kB in B-Cell Differentiation and LymphomagenesisR01CA157660 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KLEIN, ULF · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA157660NCI NIH HHS T32 CA009503
6 · The paper itself

Abstract

The NF-κB signaling cascade relays external signals essential for B-cell growth and survival. This cascade is frequently hijacked by cancers that arise from the malignant transformation of germinal center (GC) B cells, underscoring the importance of deciphering the function of NF-κB in these cells. The NF-κB signaling cascade is comprised of two branches, the canonical and alternative NF-κB pathways, mediated by distinct transcription factors. The expression and function of the transcription factors of the alternative pathway, RELB and NF-κB2, in late B-cell development is incompletely understood. Using conditional deletion of relb and nfkb2 in GC B cells, we here report that ablation of both RELB and NF-κB2, but not of the single transcription factors, resulted in the collapse of established GCs. RELB/NF-κB2 deficiency in GC B cells was associated with impaired cell-cycle entry and reduced expression of the cell-surface receptor inducible T-cell costimulator ligand that promotes optimal interactions between B and T cells. Analysis of human tonsillar tissue revealed that plasma cells and their precursors in the GC expressed high levels of NF-κB2 relative to surrounding lymphocytes. Accordingly, deletion of nfkb2 in murine GC B cells resulted in a dramatic reduction of antigen-specific antibody-secreting cells, whereas deletion of relb had no effect. These results demonstrate that the transcription factors of the alternative NF-κB pathway control distinct stages of late B-cell development, which may have implications for B-cell malignancies that aberrantly activate this pathway.

Indexed as

AnimalsB-LymphocytesCD40 AntigensCells, CulturedGerminal CenterHumansMiceNF-kappa BSignal TransductionTranscription Factor RelBTranscription FactorsCD40 AntigensNF-kappa BRelb protein, mouseTranscription Factor RelBTranscription Factorsgerminal center B cellNF-κB transcription factorsplasma cell

Identifiers

PMID27457956
PMCPMC4987794
OpenAlexW2499999511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.